ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Kidney transplantation"

  • 2022 American Transplant Congress

    Circulating and Intragraft Donor (HLA)-Specific B Cells Drive Allograft Rejection After Kidney Transplantation

    A. Torija1, N. Bolaños1, L. Donadeu1, M. Meneghini2, I. Torres2, A. Gabaldon2, M. Gomà3, E. Crespo1, F. Moreso4, O. Bestard2

    1Vall d'Hebron Research Institute (VHIR), Barcelona, Spain, 2Vall d'Hebron University Hospital, Barcelona, Spain, 3Bellvitge University Hospital, Barcelona, Spain, 4Vall d'Heron University Hospital, Barcelona, Spain

    *Purpose: Besides donor-specific antibodies (DSA), circulating donor(HLA)-specific memory B cells (mBc) have also shown to play a deleterious role driving antibody-mediated rejection (ABMR) in kidney…
  • 2022 American Transplant Congress

    Pre-Transplant Desensitization Utilizing Intravenous Immune-Globulin and Tocilizumab: A Single Center Experience

    I. Moinuddin, M. Miles, S. Sterling, A. Brown, P. Kimball, G. Gupta

    Virginia Commonwealth University Health System, Richmond, VA

    *Purpose: Highly sensitized end stage kidney disease patients face a huge barrier to transplant due to lack of effective pre-transplant desensitization therapies. Various strategies have…
  • 2022 American Transplant Congress

    Clinical Validation of Automated Urinary Chemokine Assays for Non-Invasive Detection of Kidney Transplant Rejection: A Large Prospective Cohort Study

    E. Van Loon1, C. Tinel1, J. Callemeyn1, M. Coemans1, A. Van Craenenbroeck1, T. Vaulet2, D. Anglicheau3, M. Naesens1

    1Microbiology, Immunology and Transplantation, KU Leuven, Leuven, Belgium, 2ESAT STADIUS Center for Dynamical Systems, KU Leuven, Leuven, Belgium, 3Department of Nephrology and Kidney Transplantation, Necker Hospital, Paris, France

    *Purpose: Non-invasive diagnostic markers for kidney transplant rejection can provide useful information but often do not reach the clinical implementation stage. The chemokines CXCL9 and…
  • 2022 American Transplant Congress

    Moving Beyond the Waitlist in Measurement of Access in Kidney Transplantation

    L. C. McMichael, D. T. Chang, M. Kadatz, J. Gill

    University of British Columbia, Vancouver, BC, Canada

    *Purpose: Studies limited to waitlist candidates have suggested better access to kidney transplantation and fewer disparities in acesss since the new kidney allocation system (KAS)…
  • 2022 American Transplant Congress

    Longitudinal Characterization of the Microvirome in a Cohort of Renal Transplant Recipients

    A. C. Johnson, G. Karadkhele, C. P. Larsen

    Emory University, Atlanta, GA

    *Purpose: The selective targeting of T cells in transplant immunosuppression medications leads to a high rate of viral infections, with different immunosuppression regimens resulting in…
  • 2022 American Transplant Congress

    Conversion to Everolimus-Based Immunosuppression Regimen with Calcineurin Inhibitor Reduction Ameliorates Histological Damage in Kidney Transplant Recipients with Calcineurin Inhibitor-Induced Nephrotoxicity

    K. Hotta, N. Iwahara, T. Tanabe, N. Shinohara

    Hokkaido University Hospital, Sapporo, Japan

    *Purpose: In the last two decades, the short-term results for kidney transplantation (KTX) have improved owing to the use of calcineurin inhibitors (CNIs). However, long-term…
  • 2022 American Transplant Congress

    Cold Pulsatile Perfusion Preservation of Deceased Donor Kidneys Did Not Improve Delayed Graft Function Rates in Most Transplants Due to Longer Cold Ischemia Times Offsetting Much of the Benefit, Analysis of SRTR Database

    D. S. Keith, E. Lessmann

    Kidney Transplant, Ascension Sacred Heart Hospital, Pensacola, FL

    *Purpose: To determine the impact of cold pulsatile perfusion preservation (CPPP) on delayed graft function (DGF) in a national cohort of US kidney transplants as…
  • 2022 American Transplant Congress

    Prediction of Delayed Graft Function After Deceased Donor Kidney Transplantation Using Machine Learning and Sequential Donor Data

    J. Sageshima1, J. Yu1, H. Lala Gul1, F. De Leon1, N. Goussous1, N. Mineyev1, P. Than1, K. Jen2, R. Perez1

    1Surgery, University of California Davis Health, Sacramento, CA, 2Pathology, University of California Davis Health, Sacramento, CA

    *Purpose: Delayed graft function (DGF) has been associated with adverse kidney transplant outcomes. Accurate prediction of DGF before surgery will help select organs and candidates…
  • 2022 American Transplant Congress

    Deep Learning Identifies Arterial Intimal Fibrosis in Kidney Transplant Biopsies

    K. Liu1, Z. Yi2, S. Ward3, F. Salem3, W. Zhang2

    1Nephrology, Icahn School of Medicine at Mount Sinai, New York, NY, 2Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, 3Molecular and Cell Based Medicine, Icahn School of Medicine at Mount Sinai, New York, NY

    *Purpose: Arterial intimal fibrosis (AIF) is the excessive fibrotic tissue formation in the intima of arteries indicative of poor graft function after kidney transplant. Visual…
  • 2022 American Transplant Congress

    DCD and AKI Kidneys Experiencing DGF as a Platform for the Study of Adaptive Repair

    B. Bussolati1, S. Da Sacco2, A. Asthana3, L. N. Byers3, L. Perin4, M. S. Garner3, B. Sharda3, A. C. Farney3, C. J. Jay3, R. J. Stratta3, S. J. Walker5, G. Orlando3

    1University of Turin, Turin, Italy, 2Children Hospital Los Angeles, Los Angeles, NC, 3Wake Forest Baptist Medical Center, Winston-Salem, NC, 4Children Hospital Los Angeles, Los Angeles, CA, 5WFIRM, Winston-Salem, NC

    *Purpose: AKI and DCD renal allografts are at high risk for DGF, yet the majority of these kidneys will eventually recover and attain good function…
  • « Previous Page
  • 1
  • …
  • 57
  • 58
  • 59
  • 60
  • 61
  • …
  • 531
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2026 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences